Kisqali (Ribociclib): Side Effects and What to Expect Yerbba – Breast Cancer 7:18 3 weeks ago 1 669 Скачать Далее
ADAPT trial: Endocrine + ribociclib vs. chemotherapy in HR+/HER2- early breast cancer VJOncology 1:41 5 months ago 224 Скачать Далее
Study of Ribociclib and PDR001 in HR+ Metastatic Breast Cancer Dana-Farber Cancer Institute 7:23 4 years ago 3 523 Скачать Далее
NATALEE and monarchE: ribociclib and abemaciclib in HR+/HER2- breast cancer VJOncology 1:48 2 months ago 197 Скачать Далее
RIBECCA: ribociclib, a CDK4/6 inhibitor in ER+ breast cancer VJOncology 1:26 3 years ago 612 Скачать Далее
Safety and efficacy of ribociclib and letrozole in advanced breast cancer – the MONALEESA-2 trial VJOncology 2:49 7 years ago 2 527 Скачать Далее
RIGHT Choice: ribociclib + ET vs combo chemo in aggressive HR+/HER2− advanced breast cancer VJOncology 2:46 1 year ago 1 685 Скачать Далее
MONALEESA-2: ribociclib + letrozole in pts with de novo metastatic disease and late recurrence VJOncology 1:29 1 year ago 614 Скачать Далее
Stage 4 Cancer: Starting Zometa and Kisqali (ribociclib) Dee Doherty 14:50 10 months ago 14 746 Скачать Далее
Early RIBECCA results: ribociclib with letrozole for metastatic breast cancer VJOncology 1:40 5 years ago 1 001 Скачать Далее
Adding ribociclib to endocrine therapy shows an improvement in invasive DFS in HR+/HER2 BC patients ecancer 3:08 1 year ago 529 Скачать Далее
Frontline endocrine therapies and ribociclib in early stage HR+ HER2- breast cancer VJOncology 1:39 1 year ago 162 Скачать Далее
KISQALI® (ribociclib) Mechanism of Action in Metastatic Breast Cancer for Patients RedMed 7:45 3 years ago 4 615 Скачать Далее
My Targeted Therapy Experience - Ribociclib/Kisqali for Metastatic Breast Cancer Samantha Lynn 13:52 2 years ago 11 981 Скачать Далее
NATALEE: ribociclib + NSAI as adjuvant treatment in patients with HR+/HER2− early breast cancer VJOncology 2:23 6 months ago 267 Скачать Далее
Stage 4 Cancer UPDATE: Kisqali (Ribociclib), Letrozole, Zoladex and Zometa Dee Doherty 18:42 5 months ago 8 469 Скачать Далее
MAINTAIN: fulvestrant or exemestane +/- ribociclib after anti-estrogen therapy + CDK4/6i in HR+ MBC VJOncology 0:48 2 years ago 729 Скачать Далее
Dr. Becerra on Ribociclib/Letrozole in ER+/HER2- Breast Cancer OncLive 1:09 8 years ago 1 811 Скачать Далее